Aurora appoints Dr. Jonathan Page as Chief Science Officer

Aurora Cannabis Inc. has appointed of Dr. Jonathan Page, PhD as Chief Science Officer.

In this new role, Dr. Page will oversee all science-related projects at the company.

The Aurora science team develops products for the medical, wellness and adult consumer markets and focuses on delivering cultivation results in terms of yields, consistency, quality and efficiency.

Dr. Page is a globally renowned cannabis scientist, with 37 peer-reviewed publications, who was the co-lead of the Canadian team of scientists who first sequenced the cannabis genome.

His work also helped discover the biochemical pathways leading to the major cannabinoids. Prior to his appointment, Dr. Page served as CEO of recently acquired Anandia Labs, the world-leading cannabis-focused science company he co-founded.

“We are thrilled to have Jonathan join the Aurora team as Chief Science Officer,” said Aurora CEO Terry Booth. “Jonathan’s knowledge of the cannabis plant and its applications make him a globally recognized leader in the cannabis sector. With this appointment we are well-positioned to continue to innovate through the research our teams are involved in and drive new commercial products.”

“We are thrilled to have Jonathan join the Aurora team as Chief Science Officer.”

Terry Booth, Aurora

Aurora employs more than 40 PhD- and MSc-level researchers.

“Science is a critical to global competitiveness and Aurora is the cannabis industry leader on this front,” said Dr. Page.

“Science is in Aurora’s DNA. I’m very excited to take on this new position and work with our science teams to take the development of the cannabis plant and its applications to the next level.”

Dr. Page co-founded Anandia Labs, which specializes in cannabis genetics, metabolite profiling, plant breeding, disease characterization, and cultivar certification, as well as providing third party independent testing services to producers and patient-cultivators.

Dr. Page is an adjunct professor in the Botany Department at the University of British Columbia (UBC) who received his PhD from UBC, undertook postdoctoral training in Germany, and for a decade directed a lab at the National Research Council. Dr. Page is also an accomplished inventor with eight issued patents or patent applications, and a frequent lecturer on cannabis science at international conferences.

Anandia will continue to operate independently of Aurora. Dr. John Coleman, PhD will be taking over as President at Anandia.

Aurora has also promoted Dr. Shane Morris, PhD to the role of Senior Vice-President of product development and regulatory affairs. Dr. Morris had been the Vice-President in this role previously.

“Innovation and consumer focused products will be critical for future success in the global cannabis sector,” said Dr. Shane Morris. “Discovery, technical skills, quality excellence and regulatory expertise all need to be integrated in order to develop and successfully introduce those products that the global markets are looking for. Building a collaborative global team that can execute across these areas and turn ideas into revenue is what sets Aurora apart as a world leader in the cannabis industry.”

Dr. Morris and his team are responsible for numerous product innovations at Aurora, including the recent launch of Aurora Cloud, the industry’s only vape-ready CBD oil cartridge available on the Canadian medical cannabis market.

“Shane’s promotion is based on his incredible track record that has positioned Aurora’s leading product development team at the cutting edge of our industry,” said CEO Terry Booth. “Shane has delivered and proven time and again that he is exceptionally well suited to lead this function.”Cannabis Business Worldwide

Related Posts